{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:44:05Z","timestamp":1777513445902,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.clinthera.2014.09.014","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T01:37:45Z","timestamp":1413423465000},"page":"325-337","source":"Crossref","is-referenced-by-count":15,"title":["Evaluation of the Potential for Pharmacokinetic Drug\u2013Drug Interaction Between Armodafinil and Carbamazepine in Healthy Adults"],"prefix":"10.1016","volume":"37","author":[{"given":"Mona","family":"Darwish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Bond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronghua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward T.","family":"Hellriegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Philmore","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2014.09.014_bib1","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1176\/ps.2008.59.10.1175","article-title":"Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence","volume":"59","author":"Baldessarini","year":"2008","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.clinthera.2014.09.014_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archgenpsychiatry.2009.175","article-title":"National trends in psychotropic medication polypharmacy in office-based psychiatry","volume":"67","author":"Mojtabai","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2014.09.014_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/0269881113477709","article-title":"Antipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness","volume":"27","author":"Lochmann van Bennekom","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clinthera.2014.09.014_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.pra.0000265766.25495.3b","article-title":"Polypharmacy: when is it rational?","volume":"13","author":"Preskorn","year":"2007","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.clinthera.2014.09.014_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/0044011-200929020-00003","article-title":"Pharmacokinetic profile of armodafinil in healthy subjects: pooled analysis of data from three randomized studies","volume":"29","author":"Darwish","year":"2009","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.clinthera.2014.09.014_bib6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.clinthera.2006.05.013","article-title":"Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea\/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults","volume":"28","author":"Roth","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2014.09.014_bib7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0025-6196(11)60666-6","article-title":"Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study","volume":"84","author":"Czeisler","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2014.09.014_bib8","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1097\/JOM.0b013e318237a17e","article-title":"Efficacy and tolerability of armodafinil: effect on clinical condition late in the shift and overall functioning of patients with excessive sleepiness associated with shift work disorder","volume":"53","author":"Erman","year":"2011","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.clinthera.2014.09.014_bib9","first-page":"e1","article-title":"The effect of armodafinil on patient-reported functioning and quality of life in patients with excessive sleepiness associated with shift work disorder: a randomized, double-blind, placebo-controlled trial","volume":"14","author":"Erman","year":"2012","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.clinthera.2014.09.014_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1185\/030079906X100050","article-title":"The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy","volume":"22","author":"Harsh","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2014.09.014_bib11","series-title":"Nuvigil\u00ae (armodafinil) tablets [prescribing information]","year":"2013"},{"key":"10.1016\/j.clinthera.2014.09.014_bib12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1517\/17425255.2012.708338","article-title":"Pharmacokinetic evaluation of armodafinil for the treatment of bipolar depression","volume":"8","author":"Niemegeers","year":"2012","journal-title":"Exp Opin Drug Metab Toxicol"},{"key":"10.1016\/j.clinthera.2014.09.014_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-200847010-00006","article-title":"Interaction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjects","volume":"47","author":"Darwish","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2014.09.014_bib14","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4088\/JCP.09m05900gry","article-title":"Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study","volume":"71","author":"Calabrese","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2014.09.014_bib15","article-title":"Efficacy and safety of adjunctive armodafinil in adults with major depressive episodes associated with bipolar 1 disorder: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"22","author":"Calabrese","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2014.09.014_bib16","unstructured":"Bauer, M, Ketter TA, Frye MA et al. Randomized, double-blind, placebo-controlled trial of adjunctive armodafinil (150 mg\/d) in bipolar I depression: safety and primary efficacy findings. Presented at: 167th Annual Meeting of the American Psychiatric Association, May 3-7, 2014, New York, NY."},{"key":"10.1016\/j.clinthera.2014.09.014_bib17","unstructured":"Frye, MA, Ketter TA, Yang R. Efficacy and safety of armodafinil as an adjunctive therapy for the treatment of major depressive episodes associated with bipolar I disorder. Presented at: 10th International Conference on Bipolar Disorders, Miami Beach, FL, June 13-16, 2013."},{"key":"10.1016\/j.clinthera.2014.09.014_bib18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4088\/JCP.v65n0405","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes","volume":"65","author":"Weisler","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2014.09.014_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4088\/JCP.v66n0308","article-title":"Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"66","author":"Weisler","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2014.09.014_bib20","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/0006-2952(94)90071-X","article-title":"Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation","volume":"47","author":"Kerr","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clinthera.2014.09.014_bib21","series-title":"Antiepileptic Drug Interactions","first-page":"11","article-title":"Carbamazepine","author":"Patsalos","year":"2013"},{"key":"10.1016\/j.clinthera.2014.09.014_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2165\/00003088-198510010-00004","article-title":"Carbamazepine metabolism in man: induction and pharmacogenetic aspects","volume":"10","author":"Eichelbaum","year":"1985","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2014.09.014_bib23","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2125.1992.tb04089.x","article-title":"Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites","volume":"33","author":"Kudriakova","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2014.09.014_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1528-1157.1996.tb00021.x","article-title":"Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin","volume":"37","author":"Backman","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2014.09.014_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/sj.clpt.6100431","article-title":"Pharmacodynamics of carbamazepine-mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxin","volume":"84","author":"Magnusson","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2014.09.014_bib26","series-title":"Carbatrol\u00ae (carbamazepine) extended-release capsules [prescribing information]","year":"2013"},{"key":"10.1016\/j.clinthera.2014.09.014_bib27","unstructured":"U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Drug Information. Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products\u2014general considerations. March 2003. http:\/\/www.fda.gov\/downloads\/Drugs\/...\/Guidances\/ucm070124.pdf. Accessed June 13, 2013."},{"key":"10.1016\/j.clinthera.2014.09.014_bib28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0091270009347675","article-title":"No pharmacokinetic interaction between lacosamide and carbamazepine in healthy volunteers","volume":"50","author":"Cawello","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2014.09.014_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S1461145712000326","article-title":"Use of adjunctive stimulants in adult bipolar depression","volume":"16","author":"Dell\u2019Osso","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"issue":"suppl 1","key":"10.1016\/j.clinthera.2014.09.014_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/10401230600653395","article-title":"Safety of carbamazepine extended-release capsules in bipolar disorder polypharmacy","volume":"18","author":"Ginsberg","year":"2006","journal-title":"Ann Clin Psych"},{"key":"10.1016\/j.clinthera.2014.09.014_bib31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2710.2010.01170.x","article-title":"Pharmacokinetic interaction between ivabradine and carbamazepine in healthy volunteers","volume":"36","author":"Vlase","year":"2011","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.clinthera.2014.09.014_bib32","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1528-1167.2006.00815.x","article-title":"Pharmacokinetic interaction study between the new antiepileptic and CNS drug RWJ-333369 and carbamazepine in healthy adults","volume":"47","author":"Chien","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2014.09.014_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s002130000612","article-title":"Pharmacokinetic interaction between imipramine and carbamazepine in patients with major depression","volume":"154","author":"Szymura-Oleksiak","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.clinthera.2014.09.014_bib34","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.clinthera.2010.11.009","article-title":"Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: a randomized, open-label, crossover study","volume":"32","author":"Darwish","year":"2010","journal-title":"Clin Ther"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814006067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814006067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T09:25:12Z","timestamp":1538126712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291814006067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0149291814006067"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2014.09.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}